A Phase 3, Multicenter, Open-Label Extension Study to Evaluate the Long Term Efficacy and Safety of Mirikizumab in Patients with Moderately to Severely Active Ulcerative Colitis (LUCENT 3)

  • Sparrow, Miles (Primary Chief Investigator (PCI))
  • McKenzie, Jo (Project Manager)

Project: Research

Project Details

StatusActive
Effective start/end date21/05/2031/12/23

Keywords

  • Gastroenterology
  • Ulcerative colitis
  • Clinical trial